Back
Ocular Therapeutix, Inc. 10K Form
Sell
25
OCUL
Ocular Therapeutix, Inc.
Last Price:
$7.79
Seasonality Move:
-3.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OCUL News And Ratings
See the #1 stock for the next 7 days that we like better than OCUL
OCUL Financial Statistics
Sales & Book Value
| Annual Sales: | $52M |
|---|---|
| Cash Flow: | $-57.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.03 |
| Price / Book: | 2.59 |
Profitability
| EPS (TTM): | -1.43840 |
|---|---|
| Net Income (TTM): | $-265.9M |
| Gross Margin: | $45.4M |
| Return on Equity: | -73.88% |
| Return on Assets: | -52.41% |
Ocular Therapeutix, Inc. Earnings Forecast
Key Ocular Therapeutix, Inc. Financial Ratios
-
The Gross Profit Margin over the past 14 years for OCUL is 87.35%.
-
The Selling, General & Administrative Expenses for OCUL have been equal to 227.71% of Gross Profit Margin.
-
The Research & Development expenses have been 379.39% of Revenue.
-
The Net Earning history of OCUL is -511.90% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 5 years.
Ocular Therapeutix, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | OCUL |
| CUSIP: | 67576A |
| Website: | ocutx.com |
Debt
| Debt-to-Equity Ratio: | 0.12 |
|---|---|
| Current Ratio: | 15.39 |
| Quick Ratio: | 15.11 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
OCUL Technical Analysis vs Fundamental Analysis
Sell
25
Ocular Therapeutix, Inc. (OCUL)
is a Sell
Is Ocular Therapeutix, Inc. a Buy or a Sell?
-
Ocular Therapeutix, Inc. stock is rated a SellThe current Ocular Therapeutix, Inc. [OCUL] share price is $7.78. The Score for OCUL is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.